drugset / Trial / NCT05954052

A Study of Glutathione in Children With Autism Spectrum Disorder

NCT05954052

Phase 4 Terminated 6 enrolled University of Chicago
NaSingle-groupOpen-labelOther

Summary

The aim of this study is to investigate if taking a supplement called Glutathione by mouth is safe and practical for children and teenagers with Autism Spectrum Disorder (ASD). The researchers plan to involve 24 individuals with ASD and give them oral Glutathione for 12 weeks.

Timeline

Start
2019-07-01
Primary completion
2023-08-15
Completion
2023-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Glutathione Peptide 1000 mg Oral
Subject Glutathione Peptide 3000 mg Oral